UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010971
Receipt number R000012840
Scientific Title The Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial
Date of disclosure of the study information 2013/06/15
Last modified on 2021/06/20 19:38:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial

Acronym

Misago Japan Registry

Scientific Title

The Misago self-expanding rapid-exchange nitinol stent system for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial

Scientific Title:Acronym

Misago Japan Registry

Region

Japan


Condition

Condition

peripheral artery disease(femoropopliteal artery)

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The safety and efficacy for the treatment of femoropopliteal occlusive disease in a prospective multicenter observational trial with Misago self-expanding rapid-exchange nitinol stent system

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Primary patency of 12months after procedure

Key secondary outcomes

All cause mortality
Myocardial infarction
Stroke
Freedom from revascularization
Freedom from bypass surgery
Freedom from major amputation
Symptomatic improvement
Inprovement of Ankle Brachial index
Stent thrombosis rate
Stent fracture rate
Technical successful rate
Procedure complications


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.ischemic change due femoropopliteal artery occlusive disease
2.Rutherford classification category 2 to 5
3.Rest or stressed ankle brachial index<0.9

Key exclusion criteria

1.no need for stent inplantation
2.life expectancy is two years or less

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiaki Yokoi

Organization

Kishiwada Tokushukai Hospital

Division name

Cardiology

Zip code


Address

4-27-1 Kamoricho, Kishiwada City, Osaka, Japan

TEL

072-445-9915

Email

masahiko-fujihara@themis.ocn.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kaori Shimogama

Organization

Japan Endovascular Treatment Conference

Division name

Japan Endovascular Treatment Conference

Zip code


Address

3-6-40 Momochihama Sawaraku Fukuoka

TEL

092-834-2815

Homepage URL


Email

misago.registry@j-et.jp


Sponsor or person

Institute

Japan Endovascular Treatment Conference

Institute

Department

Personal name



Funding Source

Organization

Japan Endovascular Treatment Conference

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 06 Month 10 Day

Date of IRB

2013 Year 06 Month 14 Day

Anticipated trial start date

2013 Year 06 Month 15 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2015 Year 12 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Follow up periods, 1,6,12,24 months


Management information

Registered date

2013 Year 06 Month 14 Day

Last modified on

2021 Year 06 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012840


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name